The (pro)renin receptor in health and disease

Annals of Medicine

Volumn 42, Issue 1, 2010, Pages 13-18

  Nguyen, Genevieve ^a  

^a INSERM   (France)

Author keywords

Development; Diabetes; Hypertension; Organ damage; Tissue renin angiotensin system

Indexed keywords

ENZYME PRECURSOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PRORENIN; PROTEIN PRORENIN RECEPTOR; RENIN; UNCLASSIFIED DRUG;

CATALYSIS; DIABETES MELLITUS; GENE EXPRESSION; GENE MUTATION; GLOMERULOSCLEROSIS; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; UPREGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGENESIS; RATS; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 75149122361     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890903321567     Document Type: Review

References (55)

1. Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med. 2008;86:663-671
2. Danser AHJ, Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension. 2005;46:1069-1076 (Pubitemid 41533004)
3. van den Heuvel M, Batenburg WW, Danser AH. Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis? Mol Cell Endocrinol. 2009;302:213-218
4. Methot D, Silversides DW, Reudelhuber TL. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res. 1999;8:1067-1072
5. Danser AHJ, Derkx FHM, Schalekamp MADH, Hense HW, Riegger GAJ, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16:853-862
6. Sealey JE, Glorioso N, Itskovitz J, Atlas SA, Pitarresi TM, Preibisz JJ, et al. Ovarian prorenin. Clin Exp Hypertens A. 1987;9:1435-1454
7. Lumbers ER. Functions of the renin-angiotensin system during development. Clin Exp Pharmacol Physiol. 1995;22: 499-505.
8. Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endo-crinol Metab. 1992;75:906-910
9. Takimoto-Ohnishi E, Saito T, Ishida J, Ohnishi J, Sugiyama F, Yagami K, et al. Differential roles of renin and angiotensi-nogen in the feto-maternal interface in the development of complications of pregnancy. Mol Endocrinol. 2005;19: 1361-1372
10. Anton L, Brosnihan KB. Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2008;2:349-362
11. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 1999;10:2382-2391
12. Kelly DJ, Zhang Y, Moe G, Naik G, Gilbert RE. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia. 2007;50: 2398-2404
13. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med. 1985;312:1412-1417
14. Wilson DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990;323:1101-1106
15. Deinum J, Ronn B, Mathiesen E, Derkx FHM, Hop WC, Schalekamp MADH. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999;42:1006-1010
16. Peters B, Grisk O, Becher B, Wanka H, Kuttler B, Ludemann J, et al. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens. 2008;26:102-109
17. Mercure C, Prescott G, Lacombe MJ, Silversides DW, Reudelhuber TL. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension. 2009;53:1062-1069
18. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angi-otensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427
19. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009;53:1077-1082
20. Batenburg WW, Krop M, Garrelds IM, de Vries R, de Bruin RJA, Burcklé C, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007;25:2441-2453
21. Nabi AHMN, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and rennin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006; 18:483-488
22. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006;69:105-113
23. Huang Y, Noble NA, Zhang J, Xu C, Border WA. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007; 72:45-52.
24. Huang Y, Border WA, Noble NA. Functional renin receptors in renal mesangial cells. Curr Hypertens Rep. 2007;9: 133-139
25. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008;51:682-688
26. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-defi cient mice. J Am Soc Nephrol. 2006; 7:1950-1961
27. Saris JJ, 't Hoen PA, Garrelds IM, Dekkers DHW, den Dunnen JT, Lamers JMJ, et al. Prorenin induces intracel-lular signaling in cardiomyocytes independently of angi-otensin II. Hypertension. 2006;48:564-71.
28. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc fi nger protein. Circ Res. 2006;99:1355-1366
29. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin recep-tor-transgenic rats. J Am Soc Nephrol. 2007;18:1789-1795
30. Burcklé CA, Danser AHJ, Müller DN, Garrelds IM, Gasc JM, Popova E, et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 2006;47: 552-556
31. Krebs C, Hamming I, Sadaghiani S, Steinmetz OM, Meyer-Schwesinger C, Fehr S, et al. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007;72:725-730
32. Krebs C, Weber M, Steinmetz O, Meyer-Schwesinger C, Stahl R, Danser AH, et al. Effect of (pro)renin receptor inhibition by a decoy peptide on renal damage in the clipped kidney of Goldblatt rats. Kidney Int. 2008;74:823-824
33. Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol. 2008;93: 709-714
34. Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, et al. Human prorenin has 'gate and handle' regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217-22222
35. Mercure C, Thibault G, Lussier-Cacan S, Davignon J, Schiffrin EL, Reudelhuber TL. Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem. 1995;270:16355-16359
36. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the 'handle' region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114:1128-1135
37. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fi brosis in genetic hypertension. Hypertension. 2006;47:894-900.
38. Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol. 2007;18:2054-2061
39. Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, et al. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007;48;422-429
40. Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, et al. Suppression of ocular infl ammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006;47: 2686-2692
41. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, et al. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal infl ammation. Diabetes. 2009;58: 1625-1633
42. Müller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, et al. (Pro)renin receptor peptide inhibitor 'handle-region' peptide does not affect hypertensive nephro-sclerosis in Goldblatt rats. Hypertension. 2008;51:676-681
43. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008;19:743-748
44. Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, et al. Identifi cation and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffi n granules. J Biol Chem. 1998;273:10939-10947
45. Nishi T, Forgac M. The vacuolar (H+)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002;3:94-103.
46. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identifi cation of 315 genes essential for early zebrafi sh development. Proc Natl Acad Sci USA. 2004;101: 12792-12797
47. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, et al. The (pro)renin receptor. Site-specifi c and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension. 2009;54:261-269
48. Sigmund CD, Gross KW. Structure, expression, and regulation of the murine renin genes. Hypertension. 1991;18: 446-457
49. Contrepas A, Praizovic N, Duong Van Huyen JP, Lelievre-Pegorier M, Corvol P, Nguyen G. Expression of (pro)renin receptor in mouse embryonic and newborn kidney and proliferative effect of soluble (P)RR on mesangial cells. Hypertension. 2007;50:e145 (Abstract).
50. Ramser J, Abidi FE, Burckle CA, Lenski C, Toriello H, Wen G, et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet. 2005;14: 1019-1027
51. Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume CB, et al. A role of the (pro) renin receptor in neu-ronal cell differentiation. Am J Physiol Regul Integr Comp Physiol. 2009;297:R250-7.
52. L'Huillier N, Sharp MGF, Dunbar DR, Mullins JJ. On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector associated protein (M8-9). In: Frolich ED, Re RN, editors. The local cardiac renin angiotensin-aldosterone system. Springer; 2005. p. 17-34.
53. Burcklé C, Bader M. Prorenin and its ancient receptor. Hypertension. 2006;48:549-551
54. Bader M. The second life of the (pro)renin receptor. J Renin Angiotensin Aldosterone Syst. 2007;8:205-208
55. Tigerstedt R, Bergman PG. Niere und Kreislauf. Skand Arch Physiol. 1898;8:223-271